Civic Intelligence

Pharmate Inc.

EIN 83-2594201 • 501(c)3 • Boston, MA

Pub. 78 Eligible990-N Coverage

Profile

To provide highly available, affordable and accessible drug therapeutics to all individuals regardless of socioeconomic status. To expand equity in healthcare by increasing public knowledge of treatment regiments and pharmaceutical products. To develop and distribute high quality pharmaceuticals, compliant with applicable governing bodies. To advance scientific research for the betterment of human health. The organization is established exclusively for charitable, educational and scientific purposes under section 501(c)(3) of the internal revenue code, or corresponding section of any future federal tax code. (1) the corporation's purposes shall be so interpreted as to be consistent with section 501(c)(3) of the united states internal revenue code (and successor provisions), no part of its net earnings, if any, shall inure to the benefit of any private shareholder or individual, and the corporation shall not participate or intervene (by publishing or distributing statements or othewise)

PO Box 230052Boston, MA 02123

pharmate.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2021

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2021

Net Margin

30th percentile

-11%

Higher net margin than 30% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2021

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2021

Asset Growth

100th percentile

20900%

Faster asset growth than 100% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2020 to 2021

Revenue Growth

31st percentile

-24%

Faster revenue growth than 31% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2020 to 2021

Assets

Up

$210

Up $209 (+20900%) from 2020

Liabilities

Flat

$0

Flat from 2020

Net Assets

Up

$210

Up $210 from 2020

Revenue

Down

$8,632

Down $2,782 (-24%) from 2020

Expenses

Down

$9,540

Down $2,006 (-17%) from 2020

Net Income

Down

-$908

Down $776 (-588%) from 2020

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300$200$100$0Assets 2019: $19Liabilities 2019: $0Net Assets 2019: $192019Assets 2020: $1Liabilities 2020: $0Net Assets 2020: $02020Assets 2021: $210Liabilities 2021: $0Net Assets 2021: $2102021

Highlighted filing

2021

Assets$210
Liabilities$0
Net Assets$210

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$15K$10K$5.0K$0-$5.0KRevenue 2019: $13,861Expenses 2019: $14,401Net Income 2019: -$5402019Revenue 2020: $11,414Expenses 2020: $11,546Net Income 2020: -$1322020Revenue 2021: $8,632Expenses 2021: $9,540Net Income 2021: -$9082021

Highlighted filing

2021

Revenue$8,632
Expenses$9,540
Net Income-$908

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Nov 15, 2022
Return Version
2021v4.0
Gross Receipts
$8,632
Mission and Program Overview

Mission

To provide highly available, affordable and accessible drug therapeutics to all individuals regardless of socioeconomic status. To expand equity in healthcare by increasing public knowledge of treatment regiments and pharmaceutical products. To develop and distribute high quality pharmaceuticals, compliant with applicable governing bodies. To advance scientific research for the betterment of human health. The organization is established exclusively for charitable, educational and scientific purposes under section 501(c)(3) of the internal revenue code, or corresponding section of any future federal tax code. (1) the corporation's purposes shall be so interpreted as to be consistent with section 501(c)(3) of the united states internal revenue code (and successor provisions), no part of its net earnings, if any, shall inure to the benefit of any private shareholder or individual, and the corporation shall not participate or intervene (by publishing or distributing statements or othewise)

Program Services

DescriptionGrantsExpenses
Pharmate has received donations from the public to support operational, research and marketing expenses to begin planning of its services.$1,000$1,082
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Petit PierrePresidentPT$0--
Emily Helen RutkeyTreasurerPT$0--
Tabia SmithSecretary-$0--
Petit PierreDirector-$0--
Eli GelfandDirector-$0--
Penny BeuningDirector-$0--
Filing and Contact Details

Filer

Filer Name
Pharmate Inc
EIN
83-2594201
Phone
6178005804
Address
PO BOX 230052, Boston, MA 02123

Signing Officer

Name
Petit Pierre
Title
President
Phone
6178005804
Signed
2022-11-15
Supplemental Narrative

Additional Explanations

Form 990-EZ, Part I, Line 16

Description;Amount^US PATENT TRADEMARK FEE;525^Total;525^

Raw XML Appendix177 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BenefitsPaidToOrForMembersAmt00
IRS990EZ/BooksInCareOfDetail/PersonNm0Tabia Smith
IRS990EZ/BooksInCareOfDetail/PhoneNum06178005804
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0PO BOX 230052
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Boston
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd002123
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt01118
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0210
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt08632
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-908
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt080
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form1120PolFiledInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt01118
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0210
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GainOrLossFromSaleOfAssetsAmt00
IRS990EZ/GamingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt00
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt08632
IRS990EZ/GrossSalesOfInventoryAmt00
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt00
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MembershipDuesAmt00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt01118
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0210
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt01118
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0210
IRS990EZ/OccupancyRentUtltsAndMaintAmt08605
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt020
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt110
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt22
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt32
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Petit Pierre
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Emily Helen Rutkey
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Tabia Smith
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Petit Pierre
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Eli Gelfand
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5Penny Beuning
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Secretary
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5Director
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherAssetsTotalDetail/EOYAmt00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt0525
IRS990EZ/OtherRevenueTotalAmt00
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0TO PROVIDE HIGHLY AVAILABLE, AFFORDABLE AND ACCESSIBLE DRUG THERAPEUTICS TO ALL INDIVIDUALS REGARDLESS OF SOCIOECONOMIC STATUS. TO EXPAND EQUITY IN HEALTHCARE BY INCREASING PUBLIC KNOWLEDGE OF TREATMENT REGIMENTS AND PHARMACEUTICAL PRODUCTS. TO DEVELOP AND DISTRIBUTE HIGH QUALITY PHARMACEUTICALS, COMPLIANT WITH APPLICABLE GOVERNING BODIES. TO ADVANCE SCIENTIFIC RESEARCH FOR THE BETTERMENT OF HUMAN HEALTH. THE ORGANIZATION IS ESTABLISHED EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL AND SCIENTIFIC PURPOSES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, OR CORRESPONDING SECTION OF ANY FUTURE FEDERAL TAX CODE. (1) THE CORPORATION'S PURPOSES SHALL BE SO INTERPRETED AS TO BE CONSISTENT WITH SECTION 501(C)(3) OF THE UNITED STATES INTERNAL REVENUE CODE (AND SUCCESSOR PROVISIONS), NO PART OF ITS NET EARNINGS, IF ANY, SHALL INURE TO THE BENEFIT OF ANY PRIVATE SHAREHOLDER OR INDIVIDUAL, AND THE CORPORATION SHALL NOT PARTICIPATE OR INTERVENE (BY PUBLISHING OR DISTRIBUTING STATEMENTS OR OTHEWISE)
IRS990EZ/PrintingPublicationsPostageAmt0330
IRS990EZ/ProgramServiceRevenueAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Pharmate has received donations from the public to support operational, research and marketing expenses to begin planning of its services.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt01000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt01082
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt00
IRS990EZ/SaleOfAssetsGrossAmt00
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SpecialEventsNetIncomeLossAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0MA
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt09540
IRS990EZ/TotalProgramServiceExpensesAmt01082
IRS990EZ/TotalRevenueAmt08632
IRS990EZ/TransactionWithControlEntInd00
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0pharmate.org
IRS990ScheduleA/First5Years509Ind0X
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt08632
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt011414
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt013788
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt033834
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt071
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt071
IRS990ScheduleA/Post1975UBTIGrp/CurrentTaxYearMinus2YearsAmt071
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt071
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportTotal509Amt033834
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt08632
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt011414
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt013788
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/Total509Grp/TotalAmt033834
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt08632
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt011414
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt013859
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt033905
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Description;Amount^US PATENT TRADEMARK FEE;525^Total;525^
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990-EZ, Part I, Line 16
ReasonableCauseExplanation/ExplanationTxt0Delays imposed by the COVID19 pandemic.
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL2
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/LastSubmissionRqrOOBCd01
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/OOBSecurityVerificationCd011
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd01
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Petit Pierre
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/PhoneNum06178005804
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PHARMATE INC
ReturnHeader/Filer/BusinessNameControlTxt0PHAR
ReturnHeader/Filer/EIN0832594201
ReturnHeader/Filer/PhoneNum06178005804
ReturnHeader/Filer/USAddress/AddressLine1Txt0PO BOX 230052
ReturnHeader/Filer/USAddress/CityNm0Boston
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MA
ReturnHeader/Filer/USAddress/ZIPCd002123
ReturnHeader/ReturnTs02022-11-29T11:40:49-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.